T. Beppu, K. Kamada, Y. Yoshida, H. Arai, K. Ogasawara et al., Change of oxygen pressure in glioblastoma tissue under various conditions, J Neurooncol, vol.58, pp.47-52, 2002.

M. Inda, R. Bonavia, and J. Seoane, Glioblastoma multiforme: a look inside its heterogeneous nature, Cancers, vol.6, pp.226-265, 2014.

P. Vaupel, Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis, Oncologist, issue.3, pp.21-27, 2008.

S. Evans, K. Jenkins, and H. Chen, The relationship among hypoxia, proliferation, and outcome in patients with de novo glioblastoma: a pilot study, Transl Oncol, vol.3, pp.160-169, 2010.

E. A. Pérès, A. N. Gérault, S. Valable, and S. Roussel, Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe, Oncotarget, vol.6, pp.2101-2120, 2015.

L. Tran, A. Bol, D. Labar, B. Jordan, J. Magat et al., Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry, Radiother Oncol, vol.105, pp.29-35, 2012.

D. J. Mehagnoul-schipper, B. Van-der-kallen, W. Colier, M. C. Van-der-sluijs, L. Van-erning et al., Simultaneous measurements of cerebral oxygenation changes during brain activation by near-infrared spectroscopy and functional magnetic resonance imaging in healthy young and elderly subjects, Hum Brain Mapp, vol.16, pp.14-23, 2002.

T. Christen, B. Lemasson, N. Pannetier, R. Farion, C. Segebarth et al., Evaluation of a quantitative blood oxygenation level-dependent (qBOLD) approach to map local blood oxygen saturation, NMR Biomed, vol.24, pp.393-403, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00629822

B. Lemasson, T. Christen, R. Serduc, C. Maisin, A. Bouchet et al., Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model, Radiology, vol.265, pp.743-52, 2012.

C. Baudelet and B. Gallez, Current issues in the utility of blood oxygen level dependent BOLD MRI for the assessmnent of modulation in tumor oxygenation, Curr. Med. Imaging Rev, vol.1, pp.229-272, 2005.

L. Lemaire, G. Bastiat, F. Franconi, N. Lautram, and T. Duong-thi-dan, Perfluorocarbon-loaded lipid nanocapsules as oxygen sensors for tumor tissue pO2 assessment, Eur J Pharm Biopharm, vol.84, pp.479-86, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00785263

N. Khan, S. Mupparaju, H. Hou, B. B. Williams, and H. Swartz, Repeated assessment of orthotopic glioma pO(2) by multi-site EPR oximetry: a technique with the potential to guide therapeutic optimization by repeated measurements of oxygen, J Neurosci Methods, vol.204, pp.111-118, 2012.

S. Matsumoto, K. Saito, H. Yasui, H. D. Morris, J. P. Munasinghe et al., EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate, Magn Reson Med, vol.69, pp.1443-50, 2013.

B. F. Jordan, J. Magat, F. Colliez, E. Ozel, A. C. Fruytier et al., Mapping of oxygen by imaging lipids relaxation enhancement: a potential sensitive endogenous MRI contrast to map variations in tissue oxygenation, Magn Reson Med, vol.70, pp.732-776, 2013.

A. Lo-dico, S. Valtorta, C. Martelli, S. Belloli, U. Gianelli et al., Validation of an engineered cell model for in vitro and in vivo HIF-1? evaluation by different imaging modalities, Mol Imaging Biol, vol.16, pp.210-233, 2014.

R. R. Moustafa and J. Baron, Clinical review: imaging in ischaemic stroke -implications for acute management, Crit Care, vol.11, p.227, 2007.

I. Toma-dasu, A. Dasu, and A. Brahme, Quantifying tumour hypoxia by PET imaging: a theoretical analysis, Adv Exp Med Biol, vol.645, pp.267-72, 2009.

K. Tateishi, U. Tateishi, M. Sato, S. Yamanaka, H. Kanno et al., Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1? expression in patients with glioma, AJNR Am J Neuroradiol, vol.34, pp.92-101, 2013.

S. Carlin, H. Zhang, M. Reese, N. N. Ramos, Q. Chen et al., A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers, J Nucl Med, vol.55, pp.515-536, 2014.

L. M. Cher, C. Murone, N. Lawrentschuk, S. Ramdave, A. Papenfuss et al., Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in PET, and immunohistochemical studies, J Nucl Med, vol.47, pp.410-418, 2006.

S. Valable, E. Petit, S. Roussel, L. Marteau, J. Toutain et al., Complementary information from magnetic resonance imaging and (18)Ffluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model, Nucl Med Biol, vol.38, pp.781-93, 2011.

A. Corroyer-dulmont, E. A. Pérès, E. Petit, L. Durand, L. Marteau et al., Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma, Biol Chem, vol.394, pp.529-568, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01660598

K. R. Swanson, G. Chakraborty, C. H. Wang, R. Rockne, H. Harpold et al., Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas, J Nucl Med, vol.50, pp.36-44, 2009.

S. Belloli, A. Brioschi, L. S. Politi, F. Ronchetti, S. Calderoni et al., Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG, Nucl Med Biol, vol.40, pp.831-871, 2013.

T. Beppu, K. Terasaki, T. Sasaki, S. Fujiwara, H. Matsuura et al., Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma, Mol Imaging Biol, vol.16, pp.127-162, 2014.

I. N. Fleming, R. Manavaki, P. J. Blower, C. West, K. J. Williams et al., Imaging tumour hypoxia with positron emission tomography, Br J Cancer, vol.112, pp.238-50, 2015.

C. J. Koch, J. S. Scheuermann, C. Divgi, K. D. Judy, A. V. Kachur et al., Biodistribution and dosimetry of 18F-EF5 in cancer patients with preliminary comparison of 18F-EF5 uptake versus EF5 binding in human glioblastoma, Eur J Nucl Med Mol Imaging, vol.37, pp.2048-59, 2010.

A. M. Spence, M. Muzi, K. R. Swanson, F. O'sullivan, J. K. Rockhill et al., Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival, Clin Cancer Res, vol.14, pp.2623-2653, 2008.

I. Toma-dasu, J. Uhrdin, L. Antonovic, A. Dasu, S. Nuyts et al., Dose prescription and treatment planning based on FMISO-PET hypoxia, Acta Oncol, vol.51, pp.222-252, 2012.

B. Titz, K. R. Kozak, and R. Jeraj, Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data, Phys Med Biol, vol.57, pp.6079-101, 2012.

, Conflict of Interest Statement: The authors declare that the research was con